Aspiriant LLC’s Schwab US Mid-Cap ETF SCHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436K | Hold |
14,067
| – | – | 0.01% | 234 |
|
|
2025
Q4 | $423K | Sell |
14,067
-6,408
| -31% | -$191K | 0.01% | 234 |
|
|
2025
Q3 | $607K | Buy |
20,475
+4,773
| +30% | +$139K | 0.02% | 188 |
|
|
2025
Q2 | $440K | Sell |
15,702
-33,993
| -68% | -$897K | 0.01% | 212 |
|
|
2025
Q1 | $1.3M | Hold |
49,695
| – | – | 0.05% | 123 |
|
|
2024
Q4 | $1.38M | Buy |
49,695
+2,448
| +5% | +$69.8K | 0.05% | 121 |
|
|
2024
Q3 | $1.31M | Sell |
47,247
-246
| -0.5% | -$6.54K | 0.05% | 124 |
|
|
2024
Q2 | $1.23M | Buy |
47,493
+912
| +2% | +$23.9K | 0.05% | 125 |
|
|
2024
Q1 | $1.26M | Sell |
46,581
-159
| -0.3% | -$4.06K | 0.05% | 128 |
|
|
2023
Q4 | $1.17M | Sell |
46,740
-2,361
| -5% | -$54.1K | 0.05% | 134 |
|
|
2023
Q3 | $1.11M | Sell |
49,101
-84
| -0.2% | -$1.99K | 0.06% | 128 |
|
|
2023
Q2 | $1.16M | Sell |
49,185
-3,243
| -6% | -$73.1K | 0.06% | 121 |
|
|
2023
Q1 | $1.19M | Buy |
52,428
+84
| +0.2% | +$1.93K | 0.06% | 121 |
|
|
2022
Q4 | $1.14M | Hold |
52,344
| – | – | 0.06% | 119 |
|
|
2022
Q3 | $1.06M | Sell |
52,344
-9
| -0% | -$201 | 0.05% | 116 |
|
|
2022
Q2 | $1.09M | Sell |
52,353
-900
| -2% | -$20.8K | 0.05% | 116 |
|
|
2022
Q1 | $1.35M | Sell |
53,253
-1,671
| -3% | -$41.9K | 0.07% | 111 |
|
|
2021
Q4 | $1.47M | Sell |
54,924
-1,605
| -3% | -$42.8K | 0.08% | 108 |
|
|
2021
Q3 | $1.45M | Sell |
56,529
-717
| -1% | -$18.7K | 0.08% | 93 |
|
|
2021
Q2 | $1.49M | Sell |
57,246
-306
| -0.5% | -$7.9K | 0.08% | 89 |
|
|
2021
Q1 | $1.43M | Sell |
57,552
-2,544
| -4% | -$61.7K | 0.09% | 83 |
|
|
2020
Q4 | $1.36M | Sell |
60,096
-2,376
| -4% | -$49.6K | 0.09% | 81 |
|
|
2020
Q3 | $1.16M | Sell |
62,472
-1,653
| -3% | -$30.6K | 0.09% | 93 |
|
|
2020
Q2 | $1.13M | Sell |
64,125
-42,306
| -40% | -$690K | 0.1% | 74 |
|
|
2020
Q1 | $1.49M | Sell |
106,431
-21,438
| -17% | -$393K | 0.15% | 61 |
|
|
2019
Q4 | $2.56M | Sell |
127,869
-2,604
| -2% | -$50.4K | 0.24% | 52 |
|
|
2019
Q3 | $2.46M | Sell |
130,473
-17,700
| -12% | -$334K | 0.22% | 68 |
|
|
2019
Q2 | $2.83M | Sell |
148,173
-14,907
| -9% | -$279K | 0.24% | 64 |
|
|
2019
Q1 | $3.01M | Sell |
163,080
-41,313
| -20% | -$738K | 0.25% | 64 |
|
|
2018
Q4 | $3.27M | Sell |
204,393
-36,696
| -15% | -$641K | 0.25% | 57 |
|
|
2018
Q3 | $4.65M | Sell |
241,089
-30,591
| -11% | -$583K | 0.4% | 47 |
|
|
2018
Q2 | $4.97M | Sell |
271,680
-41,796
| -13% | -$756K | 0.43% | 48 |
|
|
2018
Q1 | $5.53M | Buy |
313,476
+270,822
| +635% | +$4.86M | 0.48% | 41 |
|
|
2017
Q4 | $757K | Sell |
42,654
-468,276
| -92% | -$8.08M | 0.22% | 41 |
|
|
2017
Q3 | $8.53M | Sell |
510,930
-103,677
| -17% | -$1.69M | 0.72% | 32 |
|
|
2017
Q2 | $9.87M | Sell |
614,607
-109,005
| -15% | -$1.73M | 0.86% | 26 |
|
|
2017
Q1 | $11.4M | Sell |
723,612
-38,928
| -5% | -$607K | 0.97% | 25 |
|
|
2016
Q4 | $11.5M | Buy |
762,540
+229,530
| +43% | +$3.36M | 1.04% | 21 |
|
|
2016
Q3 | $7.73M | Buy |
533,010
+13,674
| +3% | +$198K | 0.77% | 19 |
|
|
2016
Q2 | $7.38M | Sell |
519,336
-109,890
| -17% | -$1.51M | 0.7% | 21 |
|
|
2016
Q1 | $8.51M | Buy |
+629,226
| New | +$7.94M | 0.81% | 19 |
|
Other funds holding SCHM
MGIA
AA
LWMT
Aspiriant LLC's SCHM Position: Q1 2026 in Review
Aspiriant LLC held its Schwab US Mid-Cap ETF (SCHM) position steady in Q1 2026 at 14,067 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #234.
Aspiriant LLC first reported a position in SCHM in Q1 2016 and has held it in 41 quarters since. The position peaked at $11.5M in Q4 2016. 1,010 funds tracked by Wall St. Rank hold SCHM as of Q1 2026.
- Aspiriant LLC held 14,067 shares of Schwab US Mid-Cap ETF worth $436K as of Q1 2026.
- Aspiriant LLC left its Schwab US Mid-Cap ETF share count unchanged in Q1 2026.
- Schwab US Mid-Cap ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #234 holding.
- Aspiriant LLC first reported a position in Schwab US Mid-Cap ETF in Q1 2016 and has held it in 41 quarters since.
- Aspiriant LLC's Schwab US Mid-Cap ETF position peaked at $11.5M in Q4 2016.
- 1,010 funds tracked by Wall St. Rank held Schwab US Mid-Cap ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.